HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shao-Yan Hu Selected Research

Neoplasms (Cancer)

3/2017mRNA expression profiling of histone modifying enzymes in pediatric acute monoblastic leukemia.
1/2017Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells.
2/2016Microarray profiling of bone marrow long non-coding RNA expression in Chinese pediatric acute myeloid leukemia patients.
1/2016High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway.
1/2015Molecular targeting of the oncoprotein PLK1 in pediatric acute myeloid leukemia: RO3280, a novel PLK1 inhibitor, induces apoptosis in leukemia cells.
1/2015Analyzing the gene expression profile of anaplastic histology Wilms' tumor with real-time polymerase chain reaction arrays.
12/2014Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
6/2014Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.
2/2013Differential mRNA expression levels of human histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia.
12/2011ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shao-Yan Hu Research Topics

Disease

14Leukemia
10/2020 - 02/2005
11Neoplasms (Cancer)
03/2017 - 09/2011
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2021 - 06/2013
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2022 - 02/2013
5Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2020 - 06/2014
3Hematologic Diseases (Blood Diseases)
10/2020 - 04/2014
2Aplastic Anemia (Anemia, Hypoplastic)
09/2021 - 08/2015
2Hematologic Neoplasms (Hematological Malignancy)
03/2017 - 01/2016
2Graft vs Host Disease (Graft-Versus-Host Disease)
08/2015 - 06/2013
2Neoplasm Metastasis (Metastasis)
12/2011 - 09/2011
1Neuroblastoma
12/2021
1Wiskott-Aldrich Syndrome
11/2019
1Thrombocytopenia 1
02/2019
1Hemorrhage
02/2019
1Intermittent X-Linked Thrombocytopenia
02/2019
1Pancytopenia
02/2019
1Infections
02/2019
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
09/2017
1Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
03/2017
1Posterior Leukoencephalopathy Syndrome
03/2016
1Autoimmune Diseases (Autoimmune Disease)
01/2015
1Hyperplasia
12/2011
1Breast Neoplasms (Breast Cancer)
12/2011
1Esophageal Neoplasms (Esophageal Cancer)
09/2011
1Carcinoma (Carcinomatosis)
09/2011
1Residual Neoplasm
02/2005

Drug/Important Bio-Agent (IBA)

5Inosine Triphosphate (ITP)IBA
04/2020 - 06/2014
4Proteins (Proteins, Gene)FDA Link
02/2016 - 09/2011
4Biomarkers (Surrogate Marker)IBA
01/2016 - 12/2011
3Long Noncoding RNAIBA
10/2020 - 02/2016
2EnzymesIBA
03/2017 - 02/2013
2Histones (Histone)IBA
03/2017 - 02/2013
2Messenger RNA (mRNA)IBA
03/2017 - 02/2013
2Propidium (Propidium Iodide)IBA
01/2017 - 06/2016
2Annexin A5IBA
01/2017 - 06/2016
2Therapeutic UsesIBA
08/2015 - 01/2015
2Protein Isoforms (Isoforms)IBA
02/2006 - 12/2005
1Chimeric Antigen ReceptorsIBA
06/2022
1MI-773IBA
12/2021
1Busulfan (Busulfex)FDA Link
09/2021
1Pharmaceutical PreparationsIBA
02/2019
1Nonsense Codon (Nonsense Mutation)IBA
02/2019
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2018
1Interleukin-10 (Interleukin 10)IBA
09/2017
1Interferon-gamma (Interferon, gamma)IBA
09/2017
1TOR Serine-Threonine KinasesIBA
03/2017
1SincalideFDA Link
01/2017
1Cyclin D1IBA
01/2017
1GalactosidasesIBA
01/2017
1ribociclibIBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1tanespimycin (17AAG)IBA
06/2016
1Etoposide (VP 16)FDA LinkGeneric
01/2016
1Indicators and Reagents (Reagents)IBA
01/2016
1Carrier Proteins (Binding Protein)IBA
10/2015
1Oncogene Proteins (Oncogene Protein)IBA
01/2015
1Polo-Like Kinase 1IBA
01/2015
1RO3280IBA
01/2015
1Biological ProductsIBA
01/2015
1DecitabineFDA Link
12/2014
1Metallothionein 3IBA
06/2014
1DNA (Deoxyribonucleic Acid)IBA
06/2013
1calcium phosphateIBA
06/2013
1Histone Deacetylases (Histone Deacetylase)IBA
02/2013
1CurcuminIBA
02/2013
1Insulin-Like Growth Factor Binding ProteinsIBA
02/2012
1ProteomeIBA
12/2011
1Adenosine Triphosphate (ATP)IBA
12/2011
1matrigelIBA
09/2011
1sphingosine kinaseIBA
09/2011
1Transcription Factors (Transcription Factor)IBA
02/2006
1Cyclin A1IBA
02/2006
1Trypan BlueFDA Link
02/2006
1Complementary DNA (cDNA)IBA
12/2005

Therapy/Procedure

5Hematopoietic Stem Cell Transplantation
09/2021 - 06/2013
3Transplantation
09/2021 - 04/2014
2Drug Therapy (Chemotherapy)
10/2021 - 06/2013
1Induction Chemotherapy
03/2016
1Mesenchymal Stem Cell Transplantation
08/2015
1Lasers (Laser)
12/2011
1Therapeutics
12/2011
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2005